Ardent Health Inc (NYSE:ARDT)

Q4 2024 Ardent Health Partners Inc Earnings Call Transcript

Feb 27, 2025 / 02:00 PM GMT

Release Date Price: $15.16 (+8.21%)

Transcript 10-K8-K

Key Points

Positve

Ardent Health Partners Inc (ARDT) reported a robust 19% year-over-year revenue growth in Q4 2024.
The company achieved a significant 200% growth in adjusted EBITDA for the fourth quarter.
Ardent Health Partners Inc (ARDT) successfully completed its IPO, strengthening its financial position for future growth.
The acquisition of 27 new urgent care centers in Oklahoma and New Mexico is expected to increase patient volumes.
The New Mexico State Directed Payment program approval added $94 million in revenue and $65 million in EBITDA for the second half of 2024.

Negative

There is ongoing pressure from hospital-based physician subsidies, which are expected to grow above inflation rates.
The company faces industry headwinds, including elevated payer denials and subsidy pressures.
Potential legislative changes in healthcare funding could impact future financial performance.
The cybersecurity incident in Q4 2023 affected year-over-year comparisons, creating an 'easy comp' for Q4 2024.
The timing of CMS approval for the 2025 New Mexico DPP program could affect quarterly earnings recognition.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ARDT.N - Ardent Health Partners Inc
Q4 2024 Ardent Health Partners Inc Earnings Call
Feb 27, 2025 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning. My name is Audra, and I will be your conference operator today. At this time, I would like to welcome everyone to the Art and Health Partners 4th quarter 2024 earnings conference call.

Today's conference is being recorded.

All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press the star key, followed by the number one on your telephone keypad. If you would like to withdraw your question, press one again.

At this time, I would like to turn the conference over to Dave Silo, senior Vice President of Investor relations.

------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.